Petra Acquisition Inc.
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $75M
- Focus
- Cannabis
- SEC Filings
- 1810560
- Public Embarc Page
- https://embarc.com/capital/spac/1810560/PAIC/petra-acquisition
- IPO Ticker
- PAIC
SPAC Leadership
Information on the SPAC leadership.
- Chairman of the Board, Chief Executive Officer, SecretaryAndreas Typaldos
- Chief Financial Officer, DirectorSean Fitzpatrick
- DirectorDavid Dobkin
- DirectorAnthony Hayes
- DirectorRobert Nicholson
- DirectorBarry Dennis, CFA
- DirectorKimon Angelides
Target Information
Information on the SPAC target for merger.
- Company
- Revelation Biosciences, Inc.
- Presentation
- Investor Presentation (SEC) on 2022-01-13
- Description
- Revelation is "a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease."